Urosepsis Risk in Neuromyelitis Optica Spectrum Disorder Patients Administered Satralizumab-Reference-Cited by-同舟云学术

Urosepsis Risk in Neuromyelitis Optica Spectrum Disorder Patients Administered Satralizumab

Published:2023-11-15 Issue:22 Volume:62 Page:3317-3320
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Fujita Rina¹,Aratake Yuriko²,Nakata Kyoko³,Fujii Chihiro¹,Kondo Takayuki²

Affiliation:

1. Department of Neurology, Kansai Medical University Medical Center, Japan

2. Department of Neurology, Kyoto University Graduate School of Medicine, Japan

3. Non-profit Organization, MS CABIN, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/22/62_1642-23/_pdf

Reference9 articles.

1. 1. Yamamura T, Kleiter I, Fujihara K, et al. Trial of satralizumab in neuromyelitis optica spectrum disorder. N Engl J Med 381: 2114-2124, 2019.

2. 2. Rose-John S, Winthrop K, Calabrese L. The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nat Rev Rheumatol 13: 399-409, 2017.

3. 3. Koike T, Harigai M, Inokuma S, et al. Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan. J Rheumatol 41: 15-23, 2014.

4. 4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated cost of care. Crit Care Med 29: 1303-1310, 2001.

5. 5. LaBerge NB, Detterbeck A, Nooijen CFJ. Comorbidities and medical complexities of mobility device users: a retrospective study. Disabil Rehabil Assist Technol. Forthcoming.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance;Neurology and Therapy;2024-07-16